Study to Evaluate the Product Performance of a New Silicone Hydrogel Contact Lens

Sponsor
Bausch & Lomb Incorporated (Industry)
Overall Status
Completed
CT.gov ID
NCT02258139
Collaborator
(none)
38
1
1
1.2
30.4

Study Details

Study Description

Brief Summary

This will be a randomized non-dispensing study comparing the overnight corneal swelling of an eye while wearing no contact lens to the Ultra contract lens.

Condition or Disease Intervention/Treatment Phase
  • Device: B&L Investigational Contact Lens
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
38 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Study to Evaluate the Product Performance of a New Silicone Hydrogel Contact Lens
Actual Study Start Date :
Nov 3, 2014
Actual Primary Completion Date :
Dec 11, 2014
Actual Study Completion Date :
Dec 11, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Study Group 1

1st overnight visit with no contact lens; 2nd overnight visit randomized to either left or right eye for B&L Investigational Contact Lens

Device: B&L Investigational Contact Lens
The lens used in this study will be supplied by the Sponsor. All subjects will wear a -3.00D lens.

Outcome Measures

Primary Outcome Measures

  1. Percent Change in Central Corneal Thickness [8 hours]

    Percent change in central corneal thickness from evening to morning (after 8 hours with lid closed)

Secondary Outcome Measures

  1. Time to Restore Central Corneal Thickness [48 hours]

    Time (hours) to restore central corneal thickness to its baseline value after lens removal

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Be between 18 and 40 years of age (inclusive)

  • Not a current contact lens wearer (have not worn extended wear, and not worn in lenses in 6 months)

  • Able to read, comprehend and sign an informed consent

  • Willing to comply with the wear and study visit schedule

  • Monocular best-corrected distance visual acuity >/-20/25 in each eye

Exclusion Criteria:
  • Any active corneal infection, disease, injury, inflammation, past surgery, or ocular abnormality which may interfere with contact lens wear

  • Systemic or ocular allergies, which might interfere with contact lens wear

  • Systemic disease or condition, which might interfere with contact lens wear

  • Use of prescription sleep aids or alcohol within 24 hours of study appointment

  • Inability to wear contact lenses

  • Under 18 years of age

Contacts and Locations

Locations

Site City State Country Postal Code
1 Indiana University Bloomington Indiana United States 47405

Sponsors and Collaborators

  • Bausch & Lomb Incorporated

Investigators

  • Study Director: Robert Steffen, OD, MS, Bausch & Lomb Incorporated

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bausch & Lomb Incorporated
ClinicalTrials.gov Identifier:
NCT02258139
Other Study ID Numbers:
  • 14-002
First Posted:
Oct 7, 2014
Last Update Posted:
Sep 14, 2020
Last Verified:
Sep 1, 2020
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Study Group 1
Arm/Group Description 1st overnight visit with no contact lens; 2nd overnight visit randomized to either left or right eye for B&L Investigational Contact Lens B&L Investigational Contact Lens: The lens used in this study will be supplied by the Sponsor. All subjects will wear a -3.00D lens.
Period Title: Overall Study
STARTED 38
COMPLETED 30
NOT COMPLETED 8

Baseline Characteristics

Arm/Group Title Study Group 1
Arm/Group Description 1st overnight visit with no contact lens; 2nd overnight visit randomized to either left or right eye for B&L Investigational Contact Lens B&L Investigational Contact Lens: The lens used in this study will be supplied by the Sponsor. All subjects will wear a -3.00D lens.
Overall Participants 38
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
21.4
(2.8)
Sex: Female, Male (Count of Participants)
Female
23
60.5%
Male
15
39.5%

Outcome Measures

1. Primary Outcome
Title Percent Change in Central Corneal Thickness
Description Percent change in central corneal thickness from evening to morning (after 8 hours with lid closed)
Time Frame 8 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Study Group 1
Arm/Group Description 1st overnight visit with no contact lens; 2nd overnight visit randomized to either left or right eye for B&L Investigational Contact Lens B&L Investigational Contact Lens: The lens used in this study will be supplied by the Sponsor. All subjects will wear a -3.00D lens.
Measure Participants 38
Visit 1 (without lens)
4.01
(1.57)
Visit 2 (with lens)
5.57
(2.11)
2. Secondary Outcome
Title Time to Restore Central Corneal Thickness
Description Time (hours) to restore central corneal thickness to its baseline value after lens removal
Time Frame 48 hours

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Test Eye With Lens Control Eye
Arm/Group Description Test eye after lens removed Control eye in subjects with lens in test eye
Measure Participants 38 38
0 hours
0
0%
5.3
NaN
1 hours
34.2
90%
63.2
NaN
2 hours
44.7
117.6%
23.7
NaN
3 hours
15.8
41.6%
5.3
NaN
4 hours
5.3
13.9%
2.6
NaN
>4 hours
0
0%
0
NaN

Adverse Events

Time Frame 2 days
Adverse Event Reporting Description Adverse events were not coded. Therefore, source vocabulary is not applicable.
Arm/Group Title Study Group 1
Arm/Group Description 1st overnight visit with no contact lens; 2nd overnight visit randomized to either left or right eye for B&L Investigational Contact Lens B&L Investigational Contact Lens: The lens used in this study will be supplied by the Sponsor. All subjects will wear a -3.00D lens.
All Cause Mortality
Study Group 1
Affected / at Risk (%) # Events
Total / (NaN)
Serious Adverse Events
Study Group 1
Affected / at Risk (%) # Events
Total 0/38 (0%)
Other (Not Including Serious) Adverse Events
Study Group 1
Affected / at Risk (%) # Events
Total 0/38 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

Contact sponsor directly for details.

Results Point of Contact

Name/Title Study Director
Organization Bausch Health
Phone 585-338-6399
Email robert.steffen@bausch.com
Responsible Party:
Bausch & Lomb Incorporated
ClinicalTrials.gov Identifier:
NCT02258139
Other Study ID Numbers:
  • 14-002
First Posted:
Oct 7, 2014
Last Update Posted:
Sep 14, 2020
Last Verified:
Sep 1, 2020